BioSpace News Archive

Policy

Eisai completes rolling submission to the FDA of lecanemab for early Alzheimer’s disease under the accelerated approval pathway

BioArctic AB’s partner Eisai announced that they have completed the rolling submission to the U.S. FDA of a Biologics License Application under the accelerated approval pathway for the investigational anti-amyloid beta protofibril antibody lecanemab, for the treatment of mild cognitive impairment due to Alzheimer’s disease and mild AD with confirmed presence of amyloid pathology in the brain.

May 9, 2022
·
7 min read
Business

NeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary

NeoGenomics, Inc. announced the appointment of Vishal Sikri as President and Chief Commercial Officer of Inivata and the departure of former President of Inivata Dr. Clive Morris.

May 9, 2022
·
8 min read
Biomind Labs to Argument Which Psychedelic Medicines Will Lead the Industry Into Its Next Phase of Evolution at The National Gallery in London

Biomind Labs Inc. is pleased to announce that its CEO Alejandro Antalich will be debating in the “PSYCH Symposium: London 2022.

May 9, 2022
·
6 min read
Business

Verrica Pharmaceuticals Reports First Quarter 2022 Financial Results

Verrica Pharmaceuticals Inc. today announced financial results for the first quarter ended March 31, 2022.

May 9, 2022
·
10 min read
Biotech Bay

Oncology Pharma Advances Progress on Multiple Fronts Including Advanced Attention to Connect2Trials’ Commercial Development

Oncology Pharma Inc. is pleased to execute its next phase with Connect2Trials, Inc. Originally, the Company engaged with Ribera Solutions, Inc. Connect2 on its patient engagement platform for clinical trials.

May 9, 2022
·
4 min read
Policy

Biovica’s DiviTum(R)TKa at ASCO

Biovica International today announces that the company’s blood test DiviTumTKa will be included in one oral presentation and two abstracts/posters, at the world’s largest cancer congress, ASCO Annual Meeting, June 3-7, 2022, in Chicago, USA.

May 9, 2022
·
2 min read
Business

Vaxxinity Reports First Quarter 2022 Financial Results and Provides Corporate Updates

Vaxxinity, Inc. today reported financial results for the first quarter ended March 31, 2022.

May 9, 2022
·
6 min read
Bio NC

Brii Bio Announces Positive Data Demonstrating its Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, Retains Neutralizing Activity Against Omicron BA.2 Subvariant

Brii Biosciences Limited today announced new data demonstrating that its long-acting COVID-19 neutralizing antibody therapy, the amubarvimab/romlusevimab combination, retains neutralizing activity against the Omicron BA.2 SARS-CoV-2 subvariant.

May 9, 2022
·
7 min read
OBiO Technology to Present Data on OVersatile™ Platform for Process Development of Herpes Simplex Virus and Vaccinia Virus Products at the 25th ASGCT Annual Meeting

OBiO Technology today announced that research on novel manufacturing technologies via its OVersatile™ platform will be presented at the American Society of Cell & Gene Therapy (ASCGT) 25th Annual meeting on May 16-19, 2022 in Washington, D.C.

May 9, 2022
·
2 min read
Business

Spero Therapeutics to Provide Business Update and Report First Quarter 2022 Financial Results on Monday, May 16, 2022

Spero Therapeutics, Inc. (Nasdaq: SPRO) today announced that it will host a conference call and live audio webcast on Monday, May 16, 2022, at 4:30 p.m. ET to report its first quarter 2022 financial results and provide an update on its business and pipeline.

May 9, 2022
·
1 min read